Chronic PainNCT07862387
Comparing Patient-Reported Symptoms to Objective Neck Range of Motion and Physical Capacity in Women With Chronic Neck Pain.
An observational study of Chronic Pain and Neck Pain, run by Borna Farhoomand.
Trial summary
Chronic neck pain is a common health condition that causes disability and functional limitations, and while clinicians frequently rely on patient-reported questionnaires to assess symptoms, it remains unclear how accurately these self-reported measures reflect actual physical capacity. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Chronic Pain, Neck Pain
- How many people
- 96 participants
- Where
- No sites listed yet
- Study dates
- 1 Oct 2026to 28 Feb 2027
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: Female participants recruited from outpatient physical therapy and rehabilitation clinics, university campus announcements, and local community health networks.
Who may be able to join
- Presence of chronic nonspecific neck pain lasting for at least 3 months,
- Ability to understand test instructions and complete self-reported questionnaires,
- Willingness to participate in all physical performance and range of motion assessments,
- Voluntary provision of written informed consent.
Who cannot join
- Specific cervical spine pathologies, including cervical radiculopathy, myelopathy, or severe spinal stenosis,
- History of cervical spine surgery or severe neck trauma/fracture,
- Inflammatory, systemic, or autoimmune diseases affecting the musculoskeletal system (e.g., rheumatoid arthritis, ankylosing spondylitis),
- Neurological, neuromuscular, or vestibular disorders that impair balance, coordination, or strength,
- Current pregnancy,
- History of receiving physical therapy, manual therapy, or cervical injections within the past 3 months,
- Severe cognitive or psychiatric disorders preventing compliance with evaluation protocols.
About this study
Official title: Do Patient-Reported Outcomes Reflect Objective Cervical Mobility and Physical Capacity in Women With Chronic Neck Pain?
Chronic neck pain is a common health condition that causes disability and functional limitations, and while clinicians frequently rely on patient-reported questionnaires to assess symptoms, it remains unclear how accurately these self-reported measures reflect actual physical capacity. This study aims to investigate the relationship between patient-reported outcome measures and objective physical performance assessments in 98 women aged 18-45 years with chronic nonspecific neck pain. Participants will complete questionnaires evaluating perceived neck mobility (S-ROM-Neck), fear of movement (Tampa Scale for Kinesiophobia), and pain intensity (Visual Analog Scale), which will be compared against objective measurements including active cervical range of motion using a CROM device, controlled box-lifting capacity (PILE test), timed unloaded and loaded walking performance, and deep cervical flexor and extensor muscle endurance tests. Ultimately, the findings will clarify whether self-reported questionnaires are sufficient for evaluating physical capacity or if objective performance testing should be routinely integrated into clinical practice
- Conditions
- Chronic Pain, Neck Pain
- Medical subject headings
- Chronic Pain, Neck Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Women with Chronic Nonspecific Neck Pain | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Objective Cervical Range of Motion Measured by Cervical Range of Motion (CROM) Device.
Active cervical range of motion in degrees (°).
Measured: Baseline (Single evaluation session).
Perceived Cervical Range of Motion (S-ROM-Neck)
Measured: Baseline (Single evaluation session)
Pain Intensity Evaluated by Visual Analog Scale (VAS).
Measured: Baseline (Single evaluation session).
Secondary outcomes (5)
Functional Lifting Capacity Evaluated by Progressive Isoinertial Lifting Evaluation (PILE) Test.
Measured: Baseline (Single evaluation session).
Unloaded Walking Speed Evaluated by 2x20-Meter Walking Test.
Measured: Baseline (Single evaluation session).
Deep Cervical Flexor Muscle Endurance Evaluated by Cranio-Cervical Flexion Test
Measured: Baseline (Single evaluation session).
Deep Cervical Extensor Muscle Endurance Test.
Measured: Baseline (Single evaluation session).
Fear of Movement Evaluated by Tampa Scale for Kinesiophobia (TSK).
Measured: Baseline (Single evaluation session).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2026
- Study start1 Oct 2026 (estimated)
- Primary completion25 Dec 2026 (estimated)
- Study completion28 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 96 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Borna Farhoomand
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Borna Farhoomand, Pamukkale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07862387
- Sponsor's protocol ID
- E-60116787-020-922519
- Status last verified
- Sep 2026
- First submitted
- 27 Sep 2026
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No